Top in hem/onc: Investment tips, screening endoscopy in older adults

In a recent investment column, experts discussed how physicians can apply Warren Buffett’s top financial rules to decisions they make every day. It was the top story in hematology/oncology last week.

Another top story explored the benefits of screening endoscopy among older adults. Researchers found that screening otherwise healthy patients aged older than 75 years can lower the risk for colorectal cancer and mortality; however, there was no significant survival benefit among those aged older than 75 years with CVD, diabetes or other comorbidities.

Read these and more top stories in hematology/oncology below:

Warren Buffett’s top 5 rules to live by

Warren Buffett is widely considered to be the top investor of all time. Read more.

Screening endoscopy after age 75 years lowers risk for colorectal cancer incidence, death

Screening endoscopy among otherwise healthy individuals aged older than 75 years appeared to lower the risk for colorectal cancer incidence and cancer-associated mortality, according to study results published in JAMA Oncology. Read more.

FDA’s accelerated approval program: Reevaluating the need for speed

Established in 1992 in response to the HIV epidemic, the FDA’s accelerated approval program offers a valuable opportunity to make potentially lifesaving therapeutics available to patients in a timely manner. Read more.

IDEA trial establishes new standard of care for stage III colon cancer

For years, standard treatment for patients with stage III colon cancer has been adjuvant chemotherapy for 6 months following resection. Read more.

Screening strategies could reduce prostate cancer mortality, overdiagnosis among Black men

Of the known racial disparities in cancer incidence and mortality, the disproportionate burden of prostate cancer among Black men remains one of the most pronounced. Read more.